Andere Kunden interessierten sich auch für
![Genetic Predisposition to Cancer, an Issue of Hematology/Oncology Clinics of North America]( "Genetic Predisposition to Cancer, an Issue of Hematology/Oncology Clinics of North America")
Genetic Predisposition to Cancer, an Issue of Hematology/Oncology Clinics of North America64,99 €![Gynecologic Cancer, an Issue of Hematology/Oncology Clinics of North America]( "Gynecologic Cancer, an Issue of Hematology/Oncology Clinics of North America")
Gynecologic Cancer, an Issue of Hematology/Oncology Clinics of North America74,99 €![Breast Cancer, an Issue of Hematology/Oncology Clinics of North America]( "Breast Cancer, an Issue of Hematology/Oncology Clinics of North America")
Breast Cancer, an Issue of Hematology/Oncology Clinics of North America61,99 €![Head and Neck Cancer, an Issue of Hematology/Oncology Clinics of North America]( "Head and Neck Cancer, an Issue of Hematology/Oncology Clinics of North America")
Head and Neck Cancer, an Issue of Hematology/Oncology Clinics of North America74,99 €![Head and Neck Cancer, an Issue of Hematology/Oncology Clinics of North America]( "Head and Neck Cancer, an Issue of Hematology/Oncology Clinics of North America")
Head and Neck Cancer, an Issue of Hematology/Oncology Clinics of North America59,99 €![Colorectal Cancer, an Issue of Hematology/Oncology Clinics of North America]( "Colorectal Cancer, an Issue of Hematology/Oncology Clinics of North America")
Colorectal Cancer, an Issue of Hematology/Oncology Clinics of North America74,99 €![Pancreatic Cancer, an Issue of Hematology/Oncology Clinics of North America]( "Pancreatic Cancer, an Issue of Hematology/Oncology Clinics of North America")
Pancreatic Cancer, an Issue of Hematology/Oncology Clinics of North America74,99 €
Dr. Gilligan has recruited global experts to contribute articles on the topic of testes cancer. The issue is organized to mimic the clinical process of detection, treatment, and management. Included in the issue are articles on the biology, interpretation, and imaging of germ cell tumors; early stage and stage II of seminomas and nonseminomas; first, second, and third line of chemotherapy for disseminated germ cell tumors, resection of residual masses, and treatment of brain metastases.